-
A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity
- Back
Metadata
Document Title
A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity
Author
Nittayananta W. Lerdsamran H. Chutiwitoonchai N. Promsong A. Srichana T. Netsomboon K. Prasertsopon J. Kerdto J.
Affiliations
Faculty of Dentistry Thammasat University Pathum Thani Thailand; Center for Research Innovation and Biomedical Informatics Faculty of Medical Technology Mahidol University Nakhon Pathom Thailand; National Center for Genetic Engineering and Biotechnology National Science and Technology Development Agency Pathum Thani Thailand; Faculty of Medicine Princess of Naradhiwas University Narathiwat Thailand; Drug Delivery System Excellence Center Faculty of Pharmaceutical Sciences Prince of Songkla University Songkhla Hat Yai Thailand; Department of Pharmaceutical Technology Faculty of Pharmaceutical Sciences Prince of Songkla University Songkhla Hat Yai Thailand; Faculty of Pharmacy Thammasat University Pathum Thani Thailand; Thammasat Hospital Thammasat University Pathum Thani Thailand
Type
Article
Source Title
Virology Journal
ISSN
1743422X
Year
2024
Volume
21
Issue
1
Open Access
All Open Access Gold
Publisher
BioMed Central Ltd
DOI
10.1186/s12985-023-02282-x
Abstract
Background: Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza virus is still a major worldwide health concern. Plants are a good source of bioactive compounds to be used as preventive measures for both inhibiting the virus binding and enhancing mucosal innate immunity. Curcumin has been shown to possess antiviral activity and modulate innate immunity. Therefore the purpose of this study was to develop an oro-nasal film spray containing curcumin and determine its antiviral activity against SARS-CoV-2 and influenza virus infection as well as its effects on mucosal innate immunity and inflammatory cytokines in vitro. Methods: The antiviral activity of the film spray against SARS-CoV-2 influenza A/H1N1 A/H3N2 and influenza B was assessed in vitro by plaque reduction assay. Cytotoxicity of the film spray to oral keratinocytes and nasal epithelial cells was assessed by MTT assay and cytotoxicity to Vero and MDCK cells was assessed by an MTS-based cytotoxicity assay. Oral and nasal innate immune markers in response to the film spray were determined by ELISA and by a commercial Milliplex Map Kit respectively. Results: Our data show that the film spray containing curcumin can inhibit both SARS-CoV-2 and influenza virus infections while maintaining cell viability. Results obtained among 4 viruses revealed that curcumin film spray demonstrated the highest inhibitory activity against SARS-CoV-2 with the lowest EC50 of 3.15�g/ml and the highest SI value of 4.62 followed by influenza B (EC50 = 6.32�g/ml SI = 2.04) influenza A/H1N1 (EC50 = 7.24�g/ml SI = 1.78) and influenza A/H3N2 (EC50 > 12.5�g/ml SI < 1.03) respectively. Antimicrobial peptides LL-37 and HD-5 IL-6 and TNF-? produced by oral keratinocytes were significantly induced by the film spray while hBD2 was significantly reduced. Conclusion: Film spray containing curcumin possesses multiple actions against SARS-CoV-2 infection by inhibiting ACE-2 binding in target cells and enhancing mucosal innate immunity. The film spray can also inhibit influenza virus infection. Therefore the curcumin film spray may be effective in preventing the viral infection of both SARS-CoV-2 and influenza. ? 2024 The Author(s).
Keyword
COVID-19 | Curcumin | Influenza | Mucosal immunity | SARS-CoV-2
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
License
CC0
Rights
Authors
Publication Source
WOS